HomeCompareGAWK vs PFE

GAWK vs PFE: Dividend Comparison 2026

GAWK yields 3333.33% · PFE yields 6.20%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GAWK wins by $1244041712890.35M in total portfolio value
10 years
GAWK
GAWK
● Live price
3333.33%
Share price
$0.06
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1244041712890.40M
Annual income
$1,174,716,366,071,938,000.00
Full GAWK calculator →
PFE
Pfizer Inc.
● Live price
6.20%
Share price
$27.76
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$51.1K
Annual income
$27,210.54
Full PFE calculator →

Portfolio growth — GAWK vs PFE

📍 GAWK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGAWKPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GAWK + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GAWK pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GAWK
Annual income on $10K today (after 15% tax)
$283,333.33/yr
After 10yr DRIP, annual income (after tax)
$998,508,911,161,147,300.00/yr
PFE
Annual income on $10K today (after 15% tax)
$526.66/yr
After 10yr DRIP, annual income (after tax)
$23,128.96/yr
At 15% tax rate, GAWK beats the other by $998,508,911,161,124,100.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GAWK + PFE for your $10,000?

GAWK: 50%PFE: 50%
100% PFE50/50100% GAWK
Portfolio after 10yr
$622020856445.22M
Annual income
$587,358,183,035,982,600.00/yr
Blended yield
94.43%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

GAWK
No analyst data
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-0.9% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GAWK buys
0
PFE buys
0
No recent congressional trades found for GAWK or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGAWKPFE
Forward yield3333.33%6.20%
Annual dividend / share$2.00$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%13.2%
Portfolio after 10y$1244041712890.40M$51.1K
Annual income after 10y$1,174,716,366,071,938,000.00$27,210.54
Total dividends collected$1239274250481.68M$60.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: GAWK vs PFE ($10,000, DRIP)

YearGAWK PortfolioGAWK Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$344,033$333,333.33$9,161$701.38+$334.9KGAWK
2$11,085,665$10,717,549.33$8,610$859.79+$11.08MGAWK
3$334,616,633$322,754,971.08$8,366$1,081.25+$334.61MGAWK
4$9,462,934,690$9,104,894,892.71$8,483$1,405.66+$9462.93MGAWK
5$250,766,259,005$240,640,918,887.41$9,084$1,907.24+$250766.25MGAWK
6$6,228,082,462,189$5,959,762,565,053.11$10,418$2,732.78+$6228082.45MGAWK
7$144,998,525,500,125$138,334,477,265,582.72$13,007$4,193.56+$144998525.49MGAWK
8$3,165,074,899,913,431$3,009,926,477,628,297.00$18,010$7,005.87+$3165074899.90MGAWK
9$64,790,043,755,570,470$61,403,413,612,663,110.00$28,216$12,979.89+$64790043755.54MGAWK
10$1,244,041,712,890,398,500$1,174,716,366,071,938,000.00$51,081$27,210.54+$1244041712890.35MGAWK

GAWK vs PFE: Complete Analysis 2026

GAWKStock

Gawk Incorporated provides a suite of cloud communications, cloud connectivity, cloud computing, and managed cloud-based applications solutions to small, medium, and large businesses; and domestic and international voice services to communications carriers worldwide. It offers a suite of advanced data center and cloud-based services, including fault tolerant and high availability cloud servers, which comprise platform as a service, infrastructure as a service, and a content delivery network; managed network services that converge voice and data applications, structured cabling, wireless, and security services, as well as include Internet access via Ethernet or fiber at speeds ranging from 10 Mbps to 10 Gbps; and data center solutions, including cloud services, colocation services, and business continuity services, such as storage and security. The company also provides unified communications services, including device and location agnostic; wholesale services; and cloud computing service that centralizes information management, hardware, network, and infrastructure in an off-premise location, hosted and managed by the company, as well as delivers a storage and data back-up assessment service as part of its storage offering, measuring growth, and duplication benchmarked against best practices. It markets and sells its business services through distribution partners, direct sales personnel, and inside sales representatives. Gawk Incorporated was incorporated in 2011 and is based in Los Angeles, California.

Full GAWK Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this GAWK vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GAWK vs SCHDGAWK vs JEPIGAWK vs OGAWK vs KOGAWK vs MAINGAWK vs JNJGAWK vs MRKGAWK vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.